The SEC is hosting the Asia Pacific Takeovers Regulators Conference 2019, an annual platform for expanding cooperative network within the region and sharing views on regulatory frameworks and

personal expenses and the depreciation because of the expanding capacity of subsidiaries. Sincerely yours, (Mr.Pongpat Patanavanich) Managing Director

Consolidated net loss for the period (Q1) amount -4.57 million compare with the same period (Q1) for the last year amount -2.80 because the Company Cost of Market Development of Expanding the customer base and

operations & Administrative expenses increased by Baht 97.94 million or 6.79 % due to the Medical personal expenses which was in line with the increased revenue,also increased because of the expanding capacity

& Administrative expenses increased by Baht 23.54 million or 13.02 % due to the Medical personal expenses also increased because of the expanding capacity of subsidiaries. 3. Finance costs increased by Baht 13.17

increased . 1.2 Cost of hospital operations increased by Baht 33.70 million or 7.89% mainly due to the Medical personal expenses also increased because of the expanding capacity of subsidiaries. 1.3 Selling

comparing to 2018 or 11.9% mostly due to soften Ethylene and Glycerin price from ample supply and lower crude oil price. Summary of Performance For Q1 2019, the Company and its subsidiaries recorded net

despite of the drastically decline in Ethylene and Glycerin price from ample supply plus lower crude oil price. 2. In Q2 2019, Selling and Administrative Expenses was 338 MTHB, increased by 59 MTHB or 21.1

or 17.2% due the drastic decline in Ethylene and Glycerin price from ample supply plus lower crude oil price. 2. In Q3 2019, Selling and Administrative Expenses was 361 MTHB, increased by 42 MTHB or

in Ethylene and Glycerin price from ample supply plus lower crude oil price. 2. In Q1 2020, Selling and Administrative Expenses was 350 MTHB, increased by 30 MTHB or 9% comparing to Q1 2019 which